Recent News

• 04.14.2025 - NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”
• 03.13.2025 - NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025

Recent Filings

• 04.14.2025 - 8-K Current report
• 03.31.2025 - 8-K Current report
• 03.31.2025 - NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
• 03.24.2025 - EX-99.1 EX-99.1
• 03.24.2025 - 8-K Current report
• 03.12.2025 - DEFR14A Revised definitive proxy soliciting materials
• 03.07.2025 - 8-K Current report
• 02.25.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.13.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 02.11.2025 - DEF 14A Other definitive proxy statements